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Abstract
Background: Robotic-assisted gait training (RAGT) affords an opportunity to increase walking practice with
mechanical assistance from robotic devices, rather than therapists, where the child may not be able to generate a
sufficient or correct motion with enough repetitions to promote improvement. However the devices are expensive
and clinicians and families need to understand if the approach is worthwhile for their children, and how it may be
best delivered.
Methods: The objective of this review was to identify and appraise the existing evidence for the effectiveness of
RAGT for paediatric gait disorders, including modes of delivery and potential benefit. Six databases were searched
from 1980 to October 2016, using relevant search terms. Any clinical trial that evaluated a clinical aspect of RAGT
for children/adolescents with altered gait was selected for inclusion. Data were extracted following the PRISMA
approach. Seventeen trials were identified, assessed for level of evidence and risk of bias, and appropriate data
extracted for reporting.
Results: Three randomized controlled trials were identified, with the remainder of lower level design. Most individual
trials reported some positive benefits for RAGT with children with cerebral palsy (CP), on activity parameters such as
standing ability, walking speed and distance. However a meta-analysis of the two eligible RCTs did not confirm this
finding (p = 0.72). Training schedules were highly variable in duration and frequency and adverse events were either
not reported or were minimal. There was a paucity of evidence for diagnoses other than CP.
Conclusion: There is weak and inconsistent evidence regarding the use of RAGT for children with gait disorders. If
clinicians (and their clients) choose to use RAGT, they should monitor individual progress closely with appropriate
outcome measures including monitoring of adverse events. Further research is required using higher level trial design,
increased numbers, in specific populations and with relevant outcome measures to both confirm effectiveness and
clarify training schedules.
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Background
Gait disorders in children can result from a number of
conditions including cerebral palsy (CP), myelomeningo-
cele, traumatic brain injury or after orthopaedic surgery
or musculo-skeletal pathology. Such disorders can have
a profound effect on the kinematics and tempero-spatial
components of walking, as well as the participation of
children in their home, school and other natural
environments.
Rehabilitation specialists and physiotherapists are in-
terested in ways to influence sustained improvement in
quality, speed, independence and efficiency of gait to en-
hance participation of children in a variety of different
settings. Robotic-assisted gait training (RAGT) has be-
come an increasingly common rehabilitation tool over
the last decade to improve the gait pattern of people
with neurological impairment [1]. Advances in treadmill
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and robotic technology have refined ways to support the
person’s body weight, while helping the lower limbs and
torso to maintain appropriate alignment and patterns
when the person initiates and performs gait. The overall
intent for people using RAGT is to vary the degree of
active participation and degree of body-weight support
needed during functional gait, as determined by their
therapeutic goals developed with their rehabilitation
team [1]. RAGT differs from more traditional body-
weight supported treadmill training in that the robotic-
controlled exoskeleton or footplates can assist with the
specific guidance of hip, knee and ankle movements, in-
stead of the therapist supporting or guiding the person’s
body segment positioning [2].
Zwicker and Mayson [3] provided an overview of sys-
tematic reviews of all treadmill training studies for chil-
dren with motor impairments in 2010, finding the
majority of reviews have been conducted on treadmill
training per se (with or without body-weight support).
Further, they concluded that the evidence suggests that
overall treadmill training with or without support and
assistance is effective, but this effectiveness is not as
clear for different pathology populations or different
ages.
A small number of RAGT devices are on the mar-
ket or used in clinical research. The Lokomat® and
ReoAmbulator ® use a computer-driven exoskeleton to
regulate and monitor gait parameters in individuals
with a compromised gait pattern [1]. Alternatively,
the Gait Trainer GT1® uses a system of moveable
footplates to encourage walking, instead of a treadmill-
based system [4]. Additional biomechanical parameters of
gait can be monitored and recorded, and adjustments to
performance made with feedback from the supervising
therapist. Increasingly, modes of extrinsic feedback and
motivation, such as biofeedback and virtual reality game
participation, are being used in conjunction with RAGT
to facilitate the participant’s active regulation of their per-
formance [5].
While there is a growing body of evidence on the ef-
fectiveness of RAGT in adults (see systematic review for
stroke from Swinnen and colleagues [6]), evidence for
paediatric populations is not so clear [7]. Aurich and
colleagues [7] recognised the need for greater clarity for
clinicians to be able to safely apply this technology, and
assembled an expert panel to provide recommendations,
pending scientific evidence. This systematic review aims
to augment these consensus guidelines by providing a
relevant summary of the scientific evidence to date, to
both inform clinicians and to guide researchers in the
quest for more robust evidence. The research question
was ‘what is the level of evidence for the effectiveness of
the use of RAGT for paediatric gait disorders, in which
domains, and using what delivery protocols?’
Methods
Operational definition of population and intervention
Experimental studies were examined to determine the
current volume and quality of available literature on
RAGT in paediatric participants (aged 5–17 years). The
search population focused on children with gait disor-
ders of any aetiology (neurological, orthopaedic or devel-
opmental). The intervention included any dedicated
period of rehabilitation (e.g. more than a single session)
using a specified RAGT device (e.g. Lokomat ®, Gait
Trainer GT1 ®), where the effect could be distinguished
from concomitant therapy. As discussed, RAGT can pro-
vide all or part of a naturalistic gait cycle, contrasting
body weight support/treadmill training where the par-
ticipant or the therapist must provide or augment active
motion beyond that provided by the device.
Search strategy
The search strategies were influenced by the PRISMA
protocol [8]. A health sciences librarian was consulted for
the initial development of the search protocol. Search
terms included pediatric OR paediatric; lokomat OR ro-
botic assisted treadmill; child* OR adolescen* OR youth
OR young adult* OR teenager*; robotic assisted gait train-
ing; gait. Databases searched included CINAHL (1981–
2016); EMBASE (1980–2015); Cochrane Database of
Systematic Reviews (1993–2016); Physiotherapy Evidence
Database (PEDro); MEDLINE (1980–2016); and Scopus
(1960–2016). Limiters included age and language. Pearling
of the reference lists of identified studies was conducted.
Articles were included if they were:
 experimental studies (e.g. randomized controlled
trials (RCT), before/after studies);
 conducted on (majority) paediatric
participants ≤17 years; and
 specifically used RAGT as a primary intervention
method for > single session.
Articles were excluded if they:
 could not be accessed as an English-language version;
or
 were not full-text, original research (e.g. commentaries,
conference abstracts).
Any level of experimental research design was consid-
ered given the need to determine RAGT’s broad clinical
effectiveness. Other research manuscripts (e.g. literature
reviews) were considered in the initial stages to facilitate
pearling of sources, but were not included in the final
summary of evidence.
From the original list of studies generated, one re-
viewer removed studies that were obviously ineligible
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based on title. After this first cull, abstracts and/or full
texts were then reviewed by two reviewers independently
and further exclusions made. Decisions for inclusion/
exclusion were based on consensus, and facilitated by
the third reviewer as necessary. All authors had articles al-
located as first, second or third reviewer equally.
Data extraction
Two of the three potential reviewers independently ex-
tracted data, including a determination of study type and
therefore level of evidence (using the NHMRC levels of
evidence tables [9]), population characteristics, practice
setting, total number of participants, intervention (and
comparison), outcomes and results. The reported out-
comes were further categorised into the domains stipu-
lated by the International Classification of Functioning,
Disability and Health (ICF).
Risk of bias
Included articles were critically appraised by at least two
members of the research team using the risk of bias
checklist constructed by the Cochrane Collaboration
[10]. This list provides the key aspects of trial design
that avoid bias in study conduct including randomising,
blinded conduct and adequate reporting. The three au-
thors acted independently as primary or secondary re-
viewers for each study with the third allocated as
consensus arbiter as necessary.
Data management
All extracted data were reported in table form and as a
narrative synthesis. Where appropriate, data were pooled
from sufficiently homogenous studies in a meta-analysis
[10] to produce summary effects using Revman 5.
Results
Organisation of evidence: trial characteristics
Seventeen papers were identified from the search – see
Fig. 1 for the flowchart summarising the results of the
search. Of the 17 identified, three were RCTs (NHMRC
II), one used a non-randomised control group (NHMRC
III2), three used an interrupted time-series design
(NHMRC III3), and the remaining 10 were pre/post-test
design with no control (NHMRC IV). Individual studies
and their level of evidence, as described using the
NHMRC nomenclature, are summarized in Table 1.
Participant characteristics
Four hundred and eighty-six participants were recruited
across the 17 reports (Table 1). Sample sizes varied from
one participant to 89 participants in the included stud-
ies. Every study included participants with CP, with the
majority rated on the Gross Motor Function Classification
System (GMFCS) between level I and IV. Only one study
included a participant who had a GMFCS level V [11].
The type and distribution of CP were diverse, with most
studies including a variety of presentations including bilat-
eral and unilateral CP of spastic and dyskinetic forms.
One study specified its purpose as assessing the RAGT
performance of children with CP that had either crouch
gait or equinus foot posture (n = 4) [5].
Other clinical conditions besides CP were also reported.
Borggraefe and colleagues [12] included participants with
paraplegia (cause unspecified), Rett Syndrome, traumatic
brain injury, Guillain-Barré syndrome, hip dysplasia and
patella ‘luxation’ (dislocation). Meyer-Heim and colleagues
[13] also recruited participants with Guillain-Barré syn-
drome, traumatic brain injury and incomplete paraplegia
(cause unspecified), as well as haemorrhagic encephalitis
and stroke. Brutsch and colleagues [14] reported partici-
pants having myelomeningocele, systemic lupus erythema-
tosus and traumatic brain injury as well as CP.
All studies documented an age range, and the mean
age across the studies (including control groups) was
9 years 9 months. The studies by Druzbicki and col-
leagues [15] and Koenig and colleagues [16] were not in-
cluded in this calculation as no mean age was reported
and could not be independently determined.
RAGT intervention schedules
The heterogeneous aims and methods across trials
meant no consistent RAGT schedule was described –
the schedules (dosages) are summarized in Table 1 for
both the experimental and control groups. Fifteen stud-
ies used the Lokomat ® brand of RAGT, one study used
the Gait Trainer GT I ® [4] and one used a novel mobile
RAGT device called the CPWalker [17]. Most studies
described an intervention schedule of between 2 and 5
training sessions per week, over a 2–6 week testing
period. Principal aims of these studies were to investi-
gate the improvement of gross motor performance, or
kinematic/tempero-spatial performance in the ICF body
structure and function domain, from the use of RAGT.
Five studies were found and excluded as they described
participants’ involvement in a single RAGT session.
Participants’ total time spent on RAGT devices was in-
consistent. Testing schedules reflected a typical therapy
session duration, between 25 and 60 min and may have
included other warm-ups and stretching components.
No clear evidence-based guidelines regarding the devel-
opment of training schedules were articulated. For ex-
ample, there was little discussion around the use of
exercise parameters (e.g. VO2 max, heart rate) to deter-
mine a personalised training schedule for participants,
with most studies appearing to use the RAGT device ‘as
tolerated’ by the participant.
A control intervention was only employed in seven of
the studies and included variations such as an alternate
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form of feedback, [5, 14] individual physiotherapy only
[15, 18, 19], alternative exercises [4] or combined with
functional electrical stimulation [20].
Risk of bias
Risks of bias assessments for the studies are detailed in
Table 2. Scores were generally indicative of extremely
high risk of bias, with the major issues being lack of
randomization (both generation and concealment, with-
out a control group), as well as conduct issues of poor
blinding of assessors, and poor reporting of data
(Table 2). There were general sampling issues – mostly
samples of convenience from existing clinics and small
numbers with no sample size indications for the power
of the study. Clearly no study achieved blinding of par-
ticipants or personnel administering the intervention.
Outcome measures
A variety of outcome measures were reported in the
studies, some standardised and some self-developed.
The outcome measures used, their ICF domains and a
summary of findings are represented in Table 3. The
most common measures used were related to mobility,
such as the 6 min walk test (6MinWT) and 10 m walk
test (10MWT) [4, 5, 13, 19, 21–24], and the Gross Motor
Function Measure-66 (GMFM-66: items D ‘standing’; E
‘walking’) [5, 11, 13, 19, 21–25]. Other mobility-related
outcomes included functional walking capability, and in-
dependence or level of assistance for gait (functional am-
bulation classification (FAC)) [13, 23, 24].
Other outcomes included motivation to participate,
balance and gait parameters (from posturography and
3D analyses), range of motion, motivation to participate,
general levels of function (WeeFIM), as well as docu-
menting adverse effects from the use of RAGT.
Main results
Most outcomes reported in individual studies were in
the activity domain; as mentioned these were predomin-
antly for the activity of walking. Eight studies assessed
children’s preferred walking speed following RAGT.
Considering firstly the meta-analysis, we were able to
pool data from two of the three RCTs for the outcome
measure of gait speed [4, 18]. We found no significant
difference between RAGT and the comparison (exercise
or physiotherapy alone) (standardised mean difference of
0.11, 95% confidence intervals −0.48–0.70; p = 0.720. See
Fig. 2). For the remaining individual studies all (except
Fig. 1 PRISMA flow chart of included studies
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Table 1 Summary of studies, in order of level of evidence, including intervention and participant descriptors




Ages (y) Intervention Control intervention




18 6–14 RAGT + PT
20 sessions over 4/52
(45 min duration)
Individual PT only
Druzbicki 2013 [18] II
RCT
CP: SD GMFCS II and III 52 10–11 RAGT
20 sessions over 4/52
(45 min duration)
Individual PT only




18 E = 13 ± 2.8
C = 12 ± 3.1
RAGT
5 sessions (30 min RAGT
and 10 min stretching:
40 min duration) over 2/52
5 × 40 min sessions of
exercises over 2/52
Nikityuk 2016 [20] III2
pre/post test with control
CP (average GMFCS
level of III
27 E = 9.0 ± 3.67
C = 9.1 ± 4.84
RAGT + FES
15 sessions (30 min
duration) over 3/52
RAGT (no FES),
duration same as for E
Brutsch 2011 [14] III3
Interrupted time series
(two schedules)
Neurol (10): CP 5, TBI 2,
MM 2, SLE 1.
10 12.47 +/− 2.75 RAGT




2nd of 2 schedules of
feedback (30–40 min
duration)




(GMFCS II x2; III x2)
4 5.5–8 RAGT + augmented
feedback
RAGT (no FB)




18 11.5 RAGT (B)
12 sessions (30–60 min
duration) over 3/52
Control (A) period
before and after usual
physio 3/52
Bayon 2016 [17] IV
Pre/post test
CP (bilateral spastic)
GMFCS II and III
Post-SEMLS (11 &
42 months)
2 12 and 14 RAGT using novel
‘CPWalker’ 10 sessions
(60 min duration) over 5/52.
n/a
Borggraefe 2008 [21] IV




12 sessions over 3/52
(mean 34 min duration)
n/a




20 11.0 ± 5.1 RAGT
12 sessions (50 min
duration) over 3/52
n/a
Borggraefe 2010 [12] IV
Pre/post test
CP (58)
Neurol (20) Orthop (2)
Miscel (9)
89 11.4+/−4.5 RAGT









14 8.2 ± 5.4 RAGT
12 sessions (50 min
duration) over 3/52 plus
follow-up
sessions 2-3p/m over 6/12
n/a
Koenig 2008 [16] IV
Pre/post test
Descriptive case study









3–20 sessions (45 min
duration)
n/a





3–5 sessions (45–60 min
duration)
n/a




83 10.9 ± 6.1 RAGT
12 sessions (30–60 min
duration) over 3/52
n/a




67 11.3 ± 4 RAGT
At least one session
n/a
RCT randomised controlled trial, CP cerebral palsy, GMFCS gross motor function classification system, RAGT robot-assisted gait training, PT physiotherapy, SD spastic
diplegia, E experimental group, C control group, FES functional electric stimulation, Neurol neurological, TBI traumatic brain injury, MM myelomeningocele, SLE systemic
lupus erythromatosis, AB, ABA and ACA indicates types of interrupted time series design, FB feedback, n/a not applicable, SEMLs single event multiple level surgery,
Orthop orthopaedic, miscel miscellaneous, f/u follow-up, VR virtual reality, GB guillain barre
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Schroeder [19]) showed that participants’ use of RAGT
led to improvements in 10mWT performance with the
studies by Smania and colleagues [4], Patritti and col-
leagues [5], Borggraefe and colleagues [21, 22] indicating
that the changes were statistically significant at 1, 3, 4
and 6 months follow-up respectively.
Functional gross motor performance was assessed by
nine studies using the GMFM-66, items D (standing)
and/or E (walking). All studies except van Hedel [24]
showed statistically significant improvements in item D
(standing) of the GMFM. Six studies showed statistically
significant improvements in item E following RAGT
[11, 13, 19, 21, 22, 25]. Three of the eight studies
evaluating children’s walking endurance (6MinWT)
noted statistically significant improvements [4, 21, 22].
The only participation measure used was the Canadian
Occupational Performance Measure (COPM) [19] which
reported significant differences post intervention.
For the domain of body structure and function, two
studies evaluated the changes in children’s balance per-
formance following combined physiotherapy or FES and
RAGT, measured using a stabilometric platform [15, 20].
For the Druzbicki study [15], statistically significant im-
provements were noted in five of 14 balance domains
assessed in the experimental group (n = 9), compared
with no significant difference in any balance domains in
the control group who received physiotherapy interven-
tion only (n = 5). The other study [20] compared RAGT
with RAGT plus FES and found a greater percent
improvement in balance measures with the combination.
Three studies reported the enhanced effect of facilitating
active engagement among children using RAGT through
‘augmented feedback’; notably either through the use of
virtual reality games (e.g. soccer) or therapist encourage-
ment to help children change their level of response to
different training demands during RAGT [5, 14, 16].
No studies reported on any aspects of cost or cost-
benefit in relation to alternate forms of therapy.
Adverse events and effects
Table 4 summarises adverse events as reported by one
trial. Borggraefe and colleagues [12] conducted the sole
study with the primary focus on documenting adverse
events among their cohort. They report 47 adverse
events among 38 of their 89 participants, with examples
including muscle and joint pain, skin erythema and skin
lesions, often at the harness site. Five incidents were re-
ported as ‘mild-to-moderate’ [12], and overall very few
participants were excluded from RAGT due to an ad-
verse event. No other studies reported this information.
Discussion
Clinical applications and areas for future research
Overall there is weak and inconsistent evidence for the
effectiveness of RAGT for children with gait disorders.
The majority of the evidence is for children with CP and
for the benefit of improving gait attributes such as speed,
standing ability and in some instances walking distance.














Druzbicki 2010 [15] II + - - + - + 4 ‘resigned’
Druzbicki 2013 [18] II + - - + - + 17 ‘resigned’
Smania 2011 [4] II + + - + + +
Nikityuk 2016 [20] III2 - - - - - +
Brutsch 2011 [14] III3 - - - - + + Time series
Patritti 2010 [5] III3 - - - - + + Case studies
Schroeder 2014 [19] III3 - - - - + + Sample issues
Bayon 2016 [17] IV - - - - - +
Borggraefe 2008 [21] IV - - - - + + Case study
Borggraefe 2010 [25] IV - - - - + + Sample issues
Borggraefe 2010 [12] IV - - - - + +
Borggraefe 2010 [22] IV - - - - - + Lost to f/u
Koenig 2008 [16] IV - - - - + + Single case
Meyer-Heim 2007 [13] IV - - - - ? + Sample issues
Meyer-Heim 2009 [23] IV - - - - - + Sample issues
Schroeder 2014 [11] IV - - - - - - Retrospective
Van Hedel 2015 [24] IV - - - - - - Retrospective
+ = low; ? = unclear; − = high risk of bias; f/u follow-up
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Table 3 Summary of studies: outcomes, measures and results
Group studies Outcome of interest Measure Component of health




Druzbicki 2010 [15] Balance Parameters of balance
using balance platform
Exp 5/14 parameters
improved (p < 0.05).
Control – 0/14 (NSD)
Druzbicki 2013 [18] Gait 3D gait NSD











Nikityuk 2016 [20] Balance Stabilometry
Plantography
Improvements in RAGT plus
FES superior to RAGT alone






Enjoyed DVD most, but led
to reduced engagement







GMFM 66: D GMFM 66: E
3D gait
NSD
Better with augmented f/b
NSD














Bayon 2016 [17] Gait
Range of movement
3D gait
Trunk rotation &hip flex/ext
‘specific developments’ ‘improved’






GMFM 66: D GMFM 66: E








Borggraefe 2010 [12] Adverse events Number
Significance















Koenig 2008 [16] Realism of feedback Questionnaire ‘Satisfactory impression’













p < 0.001 (inpt)
p = 0.01 (outpt)
p < 0.05 (inpt)
p < 0.01 (in/outpt)
NSD
p < 0.05
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However the studies are generally of low level design,
with a small sample size and poor conduct ratings.
Therefore a clinical recommendation to adopt RAGT in
children and adolescents with gait impairment cannot be
made until more consistent findings are reported in lar-
ger RCTs.
The disparate aims and training schedules used in the
existing literature further complicate the development of
appropriate recommendations for the use of RAGT with
children. At this stage it is unclear from the scientific
evidence what intensity, duration or timing of RAGT is
best. Borggraefe and colleagues [22] do provide evidence
that a relatively intense program over 12 weeks does
seem to produce sustained benefit after 6 months how-
ever there was no control group so the effects of time
alone are not known. Interestingly, children who partici-
pate in RAGT do particularly well when virtual games
(e.g. soccer) or therapist encouragement are used to en-
hance their active participation [5, 11, 14]. While not in-
ferring that the use of virtual games is essential for
successful RAGT, it does highlight that active participa-
tion may be impeded when children’s focus is on more
passive media, such as DVDs that require little engage-
ment [14]. Rehabilitation strategies have been shown to
produce measureable neuroplastic changes in the cortex
of children with hemiplegic CP associated with improve-
ment in upper limb motor skills [26]. These improve-
ments appeared to be more consistent with active, as
opposed to passive interventions. Clinicians should con-
sider the type of feedback and motivational tools re-
quired to maintain children’s attention on their walking
and body placement during RAGT for maximum exer-
cise benefits and active motor learning.
The available evidence has not yet comprehensively
highlighted the effectiveness of RAGT at different life
stages. For example, the effect of training on children in
their early stages of acquisition of walking compared
with teenagers experiencing pubertal growth who
already have established gait patterns. Van Hedel and
colleagues [24] provide some data that suggest that chil-
dren with CP who are more severely affected may bene-
fit more than those who are less affected – particularly
in the areas of walking-related outcomes. As mentioned,
the majority of the studies were either solely children
with CP or mixed groups. Further research needs to
study well-defined groups across a range of diagnoses.
Other determinants of success have been suggested as
age and gross motor abilities [11, 19] at baseline. While
the evidence suggests RAGT may have significant clin-
ical utility and enjoyment among children, training
protocols and baseline standards of its use would be use-
ful information for clinicians so that guidelines are
evidence-based and not ad hoc.
It appears that the effectiveness of RAGT for children’s
gait can be measured with commonly used, commonly
available, activity-based outcome measures such as the
GMFM or the 10MWT and that in some cases these can
be confirmed as clinically meaningful changes. Based on
these findings, it is recommended that clinicians use
these available tools to track their clients’ changes, espe-
cially in children with CP. Schroeder and colleagues [11]
provide some early evidence for benefits in the participa-
tion domain (using the COPM) however it was a small
sample and a time series control, therefore this needs
replication in an RCT. Children with CP who partici-
pated in an aerobic exercise fitness program showed
Table 3 Summary of studies: outcomes, measures and results (Continued)


















Exp experimental group, NSD no significant difference between experimental and control group outcomes, 3D gait 3 dimensional gait analysis, 10MWT 10 m walk
test, 6MinWT 6 minute walk test, Wee FIM functional independence measure for children, FES functional electric stimulation, VR virtual reality, DVD digital video
disc, GMFM 66: D gross motor function measure 66 part D, GMFM 66: E gross motor function measure 66 part E, f/b feedback, COPM Canadian occupational
performance measure, flex/ext flexion/extension, AE adverse event, FAC functional ambulation classification, inpt inpatient, outpt outpatient, a = minimum clinically
important difference
Fig. 2 Forest plot of RAGT versus usual physiotherapy on walking speed
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improvements in physiological measures of aerobic ac-
tivity [27], but this does not appear to generalise into
daily functional activity [28] or in their level of participa-
tion or quality of life [29]. Children’s fitness levels and
strengthening would seem to be important targets for an
RAGT experience, but how this will impact on their ac-
tivity and participation levels should be a focus of future
research. There is a general paucity of research assessing
RAGT outcomes on children’s involvement in the
“personal factors”, “participation” and “environmental”
domains of the ICF. The translation of gait outcomes
into children’s meaningful life roles and environments
following RAGT is critical information for clinicians to
know, as this can shape the goals developed with fam-
ilies and children.
Finally it is of concern that only one study monitored
adverse events. Whilst the majority of those events re-
ported were minor (skin redness etc.) the rate was high
at 42%. Further research is needed to ascertain rates and
to investigate preventive measures for the 5% reported
to have adverse events sufficient to cause them to cease
the RAGT session.
Conclusion
There is weak and inconsistent evidence that RAGT
may hold benefits for children with gait disorders, par-
ticularly those with CP, who wish to improve their walk-
ing speed or standing ability. In the absence of clear
evidence for training prescription and delivery, clinicians
using RAGT should apply clinical judgement and moni-
tor individual client progress closely with appropriate
mobility measures. Further research is required using
higher level trial design, and increased numbers to con-
firm effectiveness, across a broad range of outcomes in-
cluding adverse events, and to clarify training schedules
and evidence in different populations, domains or ages.
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